Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. It primarily affects lymph nodes, including those in the axilla and upper limb. Accurate coding with ICD-10 Code C83.34 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources are allocated effectively.
ICD-10 Code C83.34 specifically identifies diffuse large B-cell lymphoma localized to the lymph nodes of the axilla and upper limb. This aggressive lymphoma can lead to significant morbidity if not diagnosed and treated promptly. The code is used in clinical documentation and billing to ensure accurate representation of the patient's condition and to facilitate appropriate treatment and resource allocation.
Diffuse large B-cell lymphoma is a hematological malignancy that arises from B-lymphocytes and is characterized by large, atypical cells. It can present as a rapidly enlarging mass in the lymph nodes, particularly in the axillary and upper limb regions. Prompt medical attention is crucial due to its aggressive nature and potential for systemic spread.
ICD-10 Code C83.34 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring that the diagnosis is accurately reflected in the medical record and facilitating appropriate billing and reimbursement.
In SOAP notes, ICD-10 Code C83.34 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse large B-cell lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Diffuse large B-cell lymphoma requires urgent medical intervention, often necessitating hospitalization for treatment. Standard approaches include chemotherapy and, in some cases, radiation therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.34 is critical for billing in hospital, emergency room, or infectious disease care settings, ensuring accurate representation of the patient's condition.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, single or initial substance. |
| 96415 | Chemotherapy administration, intravenous, each additional substance. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C83.34 for Diffuse large B-cell lymph, nodes of axilla and upper limb
What are the common symptoms of diffuse large B-cell lymphoma?
Common symptoms include painless swelling of lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and decreased appetite.
How is diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of large atypical B-cells.
What treatments are available for diffuse large B-cell lymphoma?
Treatment usually involves chemotherapy regimens such as R-CHOP, and may include radiation therapy for localized disease. Supportive care is also important to manage symptoms.
Is diffuse large B-cell lymphoma curable?
Diffuse large B-cell lymphoma is considered potentially curable, especially when diagnosed early and treated appropriately. Long-term follow-up is essential to monitor for recurrence.
Clinical Notes
SOAP notes
DAP notes
AI medical notes